HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Juan José Lasarte Selected Research
Juan José Lasarte Research Topics
Disease
41
Neoplasms (Cancer)
11/2023 - 01/2002
10
Infections
01/2016 - 05/2002
9
Hepatocellular Carcinoma (Hepatoma)
11/2023 - 12/2007
3
Melanoma (Melanoma, Malignant)
01/2022 - 05/2011
3
Virus Diseases (Viral Diseases)
01/2018 - 07/2008
3
Chronic Hepatitis C
01/2015 - 09/2003
3
Carcinoma (Carcinomatosis)
08/2012 - 10/2002
3
Fibrosis (Cirrhosis)
03/2011 - 09/2005
2
Lung Neoplasms (Lung Cancer)
01/2023 - 04/2022
2
Breast Neoplasms (Breast Cancer)
01/2023 - 11/2017
2
Inflammation (Inflammations)
01/2018 - 04/2012
2
Persistent Infection
01/2008 - 10/2003
1
Alzheimer Disease (Alzheimer's Disease)
01/2023
1
Cognitive Dysfunction
01/2023
1
Triple Negative Breast Neoplasms
01/2023
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023
1
Anosmia
01/2023
1
Hematologic Neoplasms (Hematological Malignancy)
04/2022
1
Skin Neoplasms (Skin Cancer)
01/2022
1
Carcinogenesis
06/2021
1
Bites and Stings (Sting)
01/2021
1
Liver Neoplasms (Liver Cancer)
11/2020
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2019
1
Lymphoma (Lymphomas)
01/2018
1
Leukemia
01/2018
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1
Multiple Myeloma
01/2018
1
Bronchiolitis Obliterans Syndrome
01/2017
1
Autoimmune Diseases (Autoimmune Disease)
01/2017
1
Hyperglycemia
01/2017
1
Liver Cirrhosis (Hepatic Cirrhosis)
07/2013
1
Communicable Diseases (Infectious Diseases)
01/2013
Drug/Important Bio-Agent (IBA)
13
Peptides (Polypeptides)
IBA
01/2023 - 10/2002
13
Vaccines
IBA
01/2022 - 10/2002
11
Antigens
IBA
11/2023 - 05/2002
10
Proteins (Proteins, Gene)
FDA Link
02/2021 - 01/2002
7
Immune Checkpoint Inhibitors
IBA
01/2023 - 01/2017
6
Antibodies
IBA
01/2018 - 12/2009
5
Interleukin-10 (Interleukin 10)
IBA
01/2023 - 12/2007
5
Epitopes
IBA
09/2017 - 01/2002
4
Poly I-C
IBA
01/2020 - 12/2009
4
Ligands
IBA
01/2018 - 05/2011
4
Neoplasm Antigens (Tumor Antigens)
IBA
02/2016 - 01/2002
4
Cytokines
IBA
02/2016 - 02/2003
4
Antiviral Agents (Antivirals)
IBA
01/2015 - 01/2008
4
Carcinoembryonic Antigen
IBA
04/2004 - 01/2002
3
Therapeutic Uses
IBA
01/2023 - 03/2011
3
Transforming Growth Factor beta (TGF-beta)
IBA
12/2009 - 09/2005
2
Cisplatin (Platino)
FDA Link
Generic
01/2023 - 01/2020
2
Interleukin-12 (IL 12)
IBA
09/2022 - 12/2007
2
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 01/2017
2
Methyltransferases
IBA
01/2022 - 01/2019
2
Biomarkers (Surrogate Marker)
IBA
06/2021 - 01/2017
2
bis(3',5')-cyclic diguanylic acid
IBA
01/2021 - 01/2016
2
RNA-Binding Proteins (RNA-Binding Protein)
IBA
11/2020 - 01/2018
2
poly ICLC
IBA
01/2020 - 07/2019
2
Blocking Antibodies
IBA
01/2018 - 02/2016
2
Autoantibodies
IBA
01/2017 - 01/2017
2
Imiquimod (Aldara)
FDA Link
Generic
02/2016 - 05/2011
2
Bleomycin (Blenoxane)
FDA Link
Generic
03/2011 - 09/2005
2
Transforming Growth Factor beta1 (TGF beta 1)
IBA
01/2009 - 09/2005
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
11/2023
1
Single-Domain Antibodies
IBA
01/2023
1
Chemokine CX3CL1
IBA
01/2023
1
Forkhead Transcription Factors (Forkhead Box Proteins)
IBA
01/2023
1
Messenger RNA (mRNA)
IBA
01/2023
1
Interleukin-6 (Interleukin 6)
IBA
01/2023
1
Methimazole (Thiamazole)
FDA Link
Generic
01/2023
1
Menthol
FDA Link
01/2023
1
Conditioned Culture Media
IBA
01/2023
1
RNA (Ribonucleic Acid)
IBA
09/2022
1
Luciferases
IBA
09/2022
1
Chimeric Antigen Receptors
IBA
04/2022
1
Lactic Acid (Lactate)
FDA Link
Generic
01/2022
1
Histone Methyltransferases
IBA
01/2022
1
Gemcitabine
FDA Link
01/2022
1
Essential Amino Acids
IBA
01/2022
1
Fatty Acids (Saturated Fatty Acids)
IBA
01/2022
1
Glucose (Dextrose)
FDA Link
Generic
01/2022
1
Histones (Histone)
IBA
01/2022
1
Transcription Factors (Transcription Factor)
IBA
01/2022
1
Ion Channels (Ion Channel)
IBA
01/2022
1
4,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)
IBA
01/2022
1
Cytostatic Agents
IBA
06/2021
1
Ovalbumin
IBA
11/2020
1
Programmed Cell Death 1 Receptor
IBA
01/2019
1
Combined Vaccines
IBA
01/2018
1
Chloride-Bicarbonate Antiporters
IBA
01/2018
1
Toll-Like Receptor 4
IBA
01/2018
1
carvone
IBA
01/2018
1
Blood Glucose (Blood Sugar)
IBA
01/2017
1
Insulin (Novolin)
FDA Link
01/2017
1
Nucleosomes (Nucleosome)
IBA
01/2017
1
diguanylate cyclase
IBA
01/2016
1
tremelimumab
IBA
07/2013
Therapy/Procedure
21
Therapeutics
01/2023 - 01/2002
12
Immunotherapy
11/2023 - 10/2002
2
Ablation Techniques
11/2022 - 01/2021
1
Cell- and Tissue-Based Therapy (Cell Therapy)
04/2022